British study to test mixed vaccine dose schedules in children
British researchers will look into the immune responses of children
to mixed schedules of different COVID-19 vaccines as officials try
to determine the best approach to second doses in adolescents given
a small risk of heart inflammation.
The trial will give all participants a first dose of the Pfizer-BioNTech
vaccine. That will be followed eight weeks later by either a second
full dose or a half dose of the Pfizer shot, a full dose of
Novavax's vaccine or a half dose of Moderna's shot. The trial's lead
researcher, Matthew Snape of the Oxford Vaccine Group is running
another arm of the trial in adults, giving mixed vaccine schedules
both four and 12 weeks apart, and comparing the responses. He said
the results of that would be coming "very shortly".
Vaccinated Australians promised more freedom
Prime Minister Scott Morrison on Friday pledged more freedom for the
vaccinated, even as Australia's second-largest state reported its
second highest daily rise in new COVID-19 infections this year.
Morrison said federal and state leaders would discuss vaccine
passports and expanding home quarantine when they meet later on
The states of New South Wales and Victoria are testing facial
recognition software that allows police to check if people are at
home during COVID-19 quarantine, expanding trials that have been
criticised by privacy campaigners.
Singapore PM gets COVID-19 booster shot
Singapore Prime Minister Lee Hsien Loong said on Friday he had
received a COVID-19 vaccine booster shot and urged other elderly
people to come forward to get a shot amid a new wave of infections
across the city-state.
"Cases are increasing rapidly. A booster jab will strengthen your
protection against COVID-19," Lee, 69, said in a post on his
Facebook page. Singapore started giving boosters to the elderly and
immunocompromised groups this week.
[to top of second column]
dividend threatened by lengthy school closures
Experts say a pandemic-induced economic shock and closing of schools
for more than a year has been devastating for many of Indonesia's 68
million students. Highlighting a shift from bad education outcomes
to dreadful ones, the World Bank, in a report released on Friday,
calculated that the pandemic will leave more than 80% of
15-year-olds below the minimum reading proficiency level identified
by the Organisation for Economic Cooperation and Development.
That's a sharp rise from the 70% of students who could not reach the
basic literacy benchmark in testing by the OECD's Programme for
International Student Assessment (PISA) in 2018, which put Indonesia
in the bottom 8% of 77 participating nations.
FDA revises Lilly's COVID-19 antibody combo EUA
The U.S. Food and Drug Administration said on Thursday it has
revised its emergency use authorization for Eli Lilly's COVID-19
antibody cocktail to include for use in patients who have been
exposed to the virus and are at high risk for progression to severe
The cocktail, bamlanivimab and etesevimab, was authorized in
February for use in people 12 years and above with mild-to-moderate
infection and are at high risk for progression to severe COVID-19.
However, the FDA said on Thursday the cocktail is not a substitute
for vaccination against COVID-19.
(Compiled by Karishma Singh)
[© 2021 Thomson Reuters. All rights
Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content